Dangers of Deregulation: Kobayashi Pharmaceuticals Recall Exposes Health Risks Amidst Economic Push for Growth

In the past week, Kobayashi Pharmaceutical Co. has recalled its Japanese health supplements due to serious health risks. Five people have died and over 100 people have been hospitalized after taking the company’s products, including Benikoji Choleste Help, which contain a red mold known as benikoji.

The company faced criticism for not disclosing internal problems earlier, as they were aware of issues as early as January but did not make a public announcement until March 22. Many people who consumed the supplements experienced kidney problems, and investigations are ongoing to determine the exact cause.

President Akihiro Kobayashi issued a public apology on behalf of the company, expressing deep remorse for the deaths and illnesses caused by their products. Kobayashi Pharmaceutical has recalled all affected products, including food items that contain benikoji for coloring. Japan’s health ministry has issued warnings about the recalled products, as some may have been purchased before the recall and pose health risks.

The recent deregulation initiatives aimed at boosting economic growth in Japan may be attributed to some analysts as a possible cause of the problems with Kobayashi Pharmaceutical’s supplements. However, further investigation is needed to determine if this is indeed true.